Cassava Sciences, Inc.
SAVA
$2.73
$0.155.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -7.73M | -33.76M | -27.83M | -28.41M | -22.53M |
| Gross Profit | 7.73M | 33.76M | 27.83M | 28.41M | 22.53M |
| SG&A Expenses | 63.01M | 67.91M | 58.14M | 15.74M | 16.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 132.65M | 135.75M | 131.90M | 99.28M | 105.86M |
| Operating Income | -132.65M | -135.75M | -131.90M | -99.28M | -105.86M |
| Income Before Tax | -24.34M | -17.66M | -15.37M | -47.90M | -97.22M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.34 | -17.66 | -15.37 | -47.90 | -97.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.34M | -17.66M | -15.37M | -47.90M | -97.22M |
| EBIT | -132.65M | -135.75M | -131.90M | -99.28M | -105.86M |
| EBITDA | -131.51M | -134.52M | -130.54M | -97.83M | -104.33M |
| EPS Basic | -0.44 | -0.36 | -0.39 | -1.16 | -2.32 |
| Normalized Basic EPS | -0.16 | -0.24 | -0.24 | -0.72 | -1.45 |
| EPS Diluted | -1.45 | -1.38 | -1.41 | -2.17 | -2.32 |
| Normalized Diluted EPS | -0.17 | -0.25 | -0.25 | -0.73 | -1.45 |
| Average Basic Shares Outstanding | 185.28M | 179.37M | 173.39M | 168.98M | 167.72M |
| Average Diluted Shares Outstanding | 186.38M | 180.47M | 174.49M | 170.09M | 167.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
